Clinical Research Directory
Browse clinical research sites, groups, and studies.
Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
Sponsor: Amgen
Summary
The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.
Official title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 513 in Participants With Obesity
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-09-09
Completion Date
2026-10-01
Last Updated
2026-06-22
Healthy Volunteers
Yes
Conditions
Interventions
AMG 513
AMG 513 will be administered by SC or IV injection.
Placebo
Placebo will be administered by SC or IV injection.
AMG 513
AMG 513 will be administered by SC injection.
Placebo
Placebo will be administered by SC injection.
Locations (10)
Anaheim Clinical Trials
Anaheim, California, United States
Orange County Research Center
Lake Forest, California, United States
Fomat Medical Research
Oxnard, California, United States
Translational Clinical Research LLC
Aventura, Florida, United States
Clinical Neuroscience Solutions - Jacksonville
Jacksonville, Florida, United States
New Horizon Research Center
Miami, Florida, United States
Clinical Pharmacology of Miami, LLC
Miami, Florida, United States
Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group
Union City, Georgia, United States
Lillestol Research LLC
Fargo, North Dakota, United States
Pinnacle Clinical Research
Austin, Texas, United States